Targeted RNA-carrying particles reduced bone loss in mice
In an experiment in mice with ovaries removed, targeted particles restored spongy bone structure and bone strength.
Limit: Toxicity assessment covered only major organs over the short term
Edited by Boris Djordjevic · AgingResearch.News
In mice whose ovaries had been removed, researchers tested particles designed to carry gene-silencing RNA to macrophages, a type of immune cell, in bone. This animal experiment combined targeted RNA delivery with removal of reactive oxygen molecules, which can damage cells.
The RNA targeted the gene for IRF5, a protein that helps regulate an inflammation-promoting macrophage state. The particles were designed to reach bone first and then enter macrophages. In the mice, they reduced bone loss and restored spongy bone structure and bone strength. Analyses also supported reduced inflammatory signaling and reduced development of cells that break down bone. Researchers reported no overt short-term toxicity in major organs.
Why it matters
Postmenopausal osteoporosis involves inflammation and oxidative stress as well as excessive bone breakdown. The work explored a strategy aimed at these broader contributors to the disease.
Caveats
This animal experiment did not test effectiveness in people with postmenopausal osteoporosis. The reported lack of overt toxicity was limited to major organs over the short term.
The paper
Stomatology Hospital
Bioactive Materials, Oct 14, 2026, Open access
